A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

8K views

⸱

DOI:

10.3791/56091

⸱

November 2nd, 2018

In This Article

Summary

IκB Kinase 1/α (IKK1/α CHUK) is a Ser/Thr protein kinase that is involved in a myriad of cellular activities primarily through activation of NF-κB transcription factors. Here, we describe the main steps necessary for the production and crystal structure determination of this protein.

Abstract

A class of extracellular stimuli requires activation of IKK1/α to induce generation of an NF-κB subunit, p52, through processing of its precursor p100. p52 functions as a homodimer or heterodimer with another NF-κB subunit, RelB. These dimers in turn regulate the expression of hundreds of genes involved in inflammation, cell survival, and cell cycle. IKK1/α primarily remains associated with IKK2/β and NEMO as a ternary complex. However, a small pool of it is also observed as a low molecular weight complex(es). It is unknown if the p100 processing activity is triggered by activation of IKK1/α within the larger or the smaller complex pool. Constitutive activity of IKK1/α has been detected in several cancers and inflammatory diseases. To understand the mechanism of activation of IKK1/α, and enable its use as a drug target, we expressed recombinant IKK1/α in different host systems, such as E. coli, insect, and mammalian cells. We succeeded in expressing soluble IKK1/α in baculovirus infected insect cells, obtaining mg quantities of highly pure protein, crystallizing it in the presence of inhibitors, and determining its X-ray crystal structure. Here, we describe the detailed steps to produce the recombinant protein, its crystallization, and its X-ray crystal structure determination.

Introduction

Transcriptional activities of the NF-κB family of dimeric transcription factors are required for diverse cellular functions ranging from inflammation and immunity to survival and death. These activities are stringently controlled in cells and a loss of regulation leads to various pathological conditions, including autoimmune disorders, and cancer1,2,3. In the absence of a stimulus, the activities of NF-κB are kept inhibited by IκB (Inhibitor of -κB) proteins4. The phosphorylation of specific Ser residues on IκB proteins marks t....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Preparation of Recombinant Virus Suitable for Large Scale Expression of IKK1/α

  1. P1 virus preparation32
    1. Day 1: Plate Sf9 cells (~6 X 105) (passage number less than 10) in 2 mL of Sf900 III insect cell medium in each well of a 6-well plate and incubate at 27 °C. Passage cells when they reach a density of 2 to 3 X 106 cells per mL in suspension by diluting into fresh media at a density of ~6 X 105.
    2. Day 2: Dilute 8 µL of Sf9-transfection reagent in 100 µL of Sf900 III or Grace's Insect Medium without antibiotic and serum. Vortex briefly.

Access restricted. Please log in or start a trial to view this content.

Results

Cloning and expression of different constructs of IKK1/α
Full length human IKK1/α was cloned into the baculovirus expression vector pFastBacHTa within its EcoRI and NotI restriction sites to obtain an N-terminal hexa-Histidine tagged IKK1. The tag could be removed by TEV protease digestion. Since full length IKK1/α contains flexible regions on both ends, and flexible regions usually render a protein difficult to crystallize, we cloned various truncated fragments of IK.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Production, crystallization and structure solution of two related IKK proteins
We set out to determine the X-ray crystal structure of IKK1/α with the notion that it would be a relatively straightforward exercise given our experience with IKK2/β protein production, crystallization, and structure determination. However, we were highly surprised that these two related proteins behaved very differently regarding the ease of crystallization. Despite efforts from several high-profile laboratori.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare no competing financial interests or other conflicts of interest.

Acknowledgements

We thank the staff at the beamlines 19ID, 24ID, and 13ID at Advanced Photon Source, Lemont, IL, for support during data collection on various crystals. We are grateful to Dmitry Lyumkis, Salk Institute for fetching us the low resolution cryo-EM map at early stages of EM map/model building, which was used to build the initial IKK1 molecular replacement search model. The research leading to these results has received funding from NIH grants AI064326, CA141722, and GM071862 to GG. SP is currently a Wellcome Trust DBT India Intermediate Fellow.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Cellfectin/Cellfectin IIThermo Fisher Scientific10362100Cellfectin is now discontinued, replaced by Cellfectin II
Sf900 III Insect cell mediumThermo Fisher Scientific12658-027
SF9 cellsThermo Fisher Scientific12659017
anti-IKK1 antibodyNovus BiologicalsNB100-56704Previously sold by Imgenex
anti-PentaHis antibodyQiagen34460
PVDF membraneMilliporeIPVH00010Nitrocellulose can also be used
Ni-NTA agaroseQiagen30210
Bradford assay reagentBioRad500001
Superdex 200 columnGE Healthcare28989335
Amicon concentratorMilliporeUFC801008, UFC803008, UFC201024, UFC203024
Compound ABayer
Calbiochem IKK-inhibitor XIICalbiochem401491
StaurosporineSIGMAS4400
MLN120BMilleniumGift item
AMPPNPSIGMAA2647
Dextran sulfateSIGMA51227, 42867, 31404,
Dextran sulfateAlfa AesarJ62101
PEGSIGMA93593, 81210, 88276, 95904, 81255, 89510, 92897, 81285, 95172Some of them are new Cat # on SIGMA catalogue. What we had was originally from Fluka that had different Cat #.
Crystallization Screens
Crystal Screen I and II (Crystal Screen HT)Hampton ResearchHR2-130
Index HTHampton ResearchHR2-134
PEG/Ion and PEG/Ion2 (PEG/Ion HT)Hampton ResearchHR2-139
PEGRX 1 and PEGRx 2 (PEGRx HT)Hampton ResearchHR2-086
SaltRx 1 and SaltRx 2 (SaltRx HT)Hampton ResearchHR2-136
Crystal mountsHampton ResearchHR8-188, 190, 192, 194
SynchrotronThe Advanced Photon Source (APS) at the U.S. Department of Energy’s Argonne National LaboratoryBeamline 19 IDThe Advanced Photon Source (APS) at the U.S. Department of Energy’s Argonne National Laboratory provides ultra-bright, high-energy storage ring-generated X-ray beams for research in almost all scientific disciplines.

References

  1. Xia, Y., Shen, S., Verma, I. M. NF-kappaB, an active player in human cancers. Cancer immunology research. 2 (9), 823-830 (2014).
  2. Grivennikov, S. I., Greten, F. R., Karin, M. Immunity, inflammation, and cancer. Cell. 140 (6), 883-899 (2010).
  3. Ben-Neriah, Y., Karin, M.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

IKK1 AlphaProtein ExpressionInsect CellsBaculovirus SystemProtein PurificationSize Exclusion ChromatographyProtein CrystallizationX-ray CrystallographyMolecular Replacement